| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | 0.054 | 0.9 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |